A detailed history of American Century Companies Inc transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, American Century Companies Inc holds 19,591 shares of ORMP stock, worth $46,626. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,591
Previous 19,591 -0.0%
Holding current value
$46,626
Previous $50,000 6.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$2.18 - $3.58 $656 - $1,077
301 Added 1.56%
19,591 $57,000
Q4 2023

Feb 13, 2024

BUY
$1.71 - $2.57 $32,985 - $49,575
19,290 New
19,290 $44,000
Q3 2023

Nov 13, 2023

BUY
$2.51 - $3.55 $17,507 - $24,761
6,975 Added 59.17%
18,764 $48,000
Q2 2023

Aug 14, 2023

BUY
$2.12 - $4.47 $24,992 - $52,696
11,789 New
11,789 $42,000

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92.4M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.